Skip to content

Impact of intravenous dexmedetomidine on gastrointestinal function recovery

Impact of intravenous dexmedetomidine on gastrointestinal function recovery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054698
Enrollment
Unknown
Registered
2021-12-24
Start date
2019-09-01
Completion date
Unknown
Last updated
2022-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia and postoperative gastrointestinal function

Interventions

Experimental group:Dexmedetomidine
Control Group:None

Sponsors

Bethune International Peace Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. ASA classification I-II; 2. Aged 18 to 80 years; 3. Body mass index (BMI) 20-30 kg/m^2; 4. Patients with normal cognitive function.

Exclusion criteria

Exclusion criteria: 1. Known to have gastrointestinal motility disorder; 2. Previous abdominal surgery; 3. Severe liver and kidney dysfunction; 4. Secondary or tertiary heart obstruction; 5. Slow arrhythmia with a baseline rate of less than 50 beats/min; 6. Mental disorder; 7. History of airway difficulty or delayed extubation; 8. Abuse of opioids, dexmedetomidine and other anesthetic drugs; 9. Preoperative gastrointestinal bleeding (blood volume >800 mL), emergency surgery; 10. The patient or family member refuses.

Design outcomes

Primary

MeasureTime frame
the time to first flatus;

Secondary

MeasureTime frame
time to first oral feeding;pain score;incidence of delirium;postoperative nausea and vomiting;

Countries

China

Contacts

Public ContactWu Yu

Bethune International Peace Hospital

vwuyuv@163.com+86 18633487638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026